Skip to main content

Male Factor Infertility

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Biocoat
BiocoatPA - Horsham
1 program
PICSI dishN/A1 trial
Active Trials
NCT00741494Completed801
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
The Clinical Study of Sex Chromosome VariantsN/A1 trial
Active Trials
NCT01661010Completed112
Genome & Company
Genome & CompanyKorea - Suwon
1 program
The Clinical Study of Sex Chromosome VariantsN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesThe Clinical Study of Sex Chromosome Variants
BiocoatPICSI dish

Clinical Trials (2)

Total enrollment: 913 patients across 2 trials

NCT01661010Human BioSciencesThe Clinical Study of Sex Chromosome Variants

The Clinical Study of Sex Chromosome Variants

Start: Jul 2012112 patients
N/ACompleted

Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI)

Start: Aug 2008801 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.